Park Avenue Securities LLC increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 28.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned ...

Learn more about whether Bio-Rad Laboratories, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor ...

New kits are designed to offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes.

Bio-Rad Laboratories (NYSE:BIO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to ...

Rad's challenges in the life sciences tools market, cautious approach, R&D spending, stake in Sartorius, and growth potential ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Bio-Rad Laboratories (BIO) one of those stocks right now? A quick glance at the ...

S&P 500 Shake-Up: New Entrants Driving Market Momentum The S&P 500 is a widely recognized benchmark for the US stock market, and it has undergone reshuffling due to the quarterly rebalancing ...